Cologne The Supervisory Board of AYOXXA Biosystems GmbH is pleased to announce that following his initial assumption of the duties of CEO in October 2016, Rodney Turner will continue to lead the company as CEO on a permanent basis effective immediately. The board and Mr. Turner are aligned on the future growth opportunities for AYOXXA […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Sam A. Samad, Senior Vice President and Chief Financial Officer. He will join the company on January 6th, 2017. Sam will be responsible for the company’s finance, accounting, investor relations, internal audit and treasury functions. He joins Illumina from Cardinal Health where he held several senior leadership positions including most recently […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today it has named Dr. Dan Kephart as its chief science officer — a new position for the company. Kephart will assume his responsibilities at Neogen effective Jan. 1. Kephart has served as research and development director for the agribusiness unit of Thermo Fisher Scientific, as well […]
Showa Denko (SDK) (TOKYO:4004) decided at its board meeting today on changes in corporate management. See here for full list of changes.
WASHINGTON — Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2017, Rainer Blair has been promoted to Executive Vice President of Danaher Corporation, with responsibility for the Company’s $5 billion Life Sciences platform. Mr. Blair, 52 years old, has served in a series of progressively more responsible general management roles since joining Danaher in 2010, and is currently the […]
BERWYN, PA – AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has elected two new Senior Vice Presidents and two new Vice Presidents and General Managers. The Senior Vice Presidents are Matthew C. French and Bruce P. Wilson. The Vice Presidents and General Managers are David W. Jordan and Prakash Mahesh. “I […]
Former Vice President and Head of the Oncology Business Unit at Jiangsu Hengrui Medicine assumes position as Chief Medical Officer at ACEA Biosciences. San Diego, CA ACEA Biosciences Inc. (ACEA), a privately owned biotechnology company focused on pioneering cell analysis instrumentation as well as the discovery and development of novel pharmaceuticals for the treatment of […]
Tom Tyner of Spectrum Mfg. Corp., is confirmed as the Chair of the ACS Committee on Analytical Reagents for 2017 Gardena, CA and New Brunswick, NJ Today, Spectrum Mfg. Corp., one the largest provider of ACS/USP chemicals, is proud to announce Tom Tyner, Vice President, Quality Assurance/Quality Control has been appointed as the 2017 Chair […]
Cambridge, UK: Synoptics, a world leader in the development and manufacture of innovative digital imaging systems for life science and clinical applications, is pleased to announce the appointment of Dr Brian Stammers as its new CEO. Brian’s wealth of experience in the life science industry will help guide Synoptics’s strategic direction to deliver innovative and […]
LA JOLLA, Calif. – Synthetic Genomics, Inc., announced today that it has appointed industry veterans Tina Nova, Ph.D., and William McKee to its board of directors. “Tina and Bill have decades of experience growing dynamic commercial organizations in new markets within the pharmaceutical and healthcare diagnostics industries,” said Oliver Fetzer, Ph.D., chief executive officer of Synthetic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
